News | May 30, 2024
Valent BioSciences opens new addition at Melnik and Shafer Biorational Research Center
Greg was also central to the planning, design, and construction of this facility
Greg was also central to the planning, design, and construction of this facility
Acquisition includes Restoret, a novel late-phase candidate for diabetic macular edema and neovascular age-related macular degeneration
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
Establishing Asymchem’s first manufacturing footprint in Europe
Operationally ready by 2029, it will be the Company’s first-ever facility to cover the full manufacturing process for ADCs
Cresset’s new India site will support the growing demands of Cresset’s APAC customer base
Acquisition encompasses a portfolio of RLT programs across a range of solid tumor indications
One form of thalidomide has the intended sedative effect but the opposite mirror-image form interferes with foetal development
Combination will create a Canadian Health Champion spanning generic, biosimilar and branded pharmaceuticals
This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
Subscribe To Our Newsletter & Stay Updated
